Tuesday, September 25, 2007
ScotusBlog notes it as having to do with preemption of claims of fraud on a federal agency, and Warner-Lambert is a party. PLAC's amicus brief [PDF] explains the details; it arose from a preemption claim relating to Michigan's partial immunity for FDA-approved drugs. The immunity is lifted if the plaintiffs can show (roughly) fraud on the FDA, which Warner-Lambert (now part of Pfizer), in Rezulin litigation, alleged was a preempted question under Buckman.
Should be interesting.
--BC (who does work for some pharma companies, but not Pfizer or Warner-Lambert to date)